Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Role of age and sex in the incidence of adverse effects among diabetic patients treated with glipizide.
Exp Ther Med
October 2024
Research and Innovation Department, King Faisal Specialist Hospital and Research Centre, Riyadh 11564, Kingdom of Saudi Arabia.
Glipizide is an antidiabetic drug that belongs to a class of medication known as sulfonylureas. It is considered one of the highly prescribed antidiabetic drugs for the treatment of type II diabetes in patients following a kidney transplant. It lowers blood glucose levels by causing the release of insulin from β-cells in the pancreas.
View Article and Find Full Text PDFEPISODE OF ACUTE HEMOLYSIS DUE TO UNDIAGNOSED GLUCOSE-6-PHOSPHATE DEHIDROGENASE DEFICIENCY IN AN ADOLESCENT WITH NEWLY DIAGNOSED TYPE 1 DIABETES MELLITUS: CASE REPORT AND REVIEW OF LITERATURE.
Acta Endocrinol (Buchar)
October 2023
Division of Pediatric Endocrinology, "Celal Bayar" University, Faculty of Medicine, Manisa, Turkey.
Glucose-6-phosphate dehydrogenase (G6PD) enzyme deficiency is common in the community. The most important clinical manifestation of G6PD deficiency is acute hemolytic anemia due to oxidative stressors. Diabetes Mellitus (DM) can precipitate hemolysis in patients with G6PD deficiency.
View Article and Find Full Text PDFChanging trend of neonatal Ca/P/Mg status in a Chinese population.
Transl Pediatr
September 2023
Department of Pediatrics, Shanghai Sixth People's Hospital, Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Background: Calcium (Ca), phosphorus (P), and magnesium (Mg) are essential elements for keeping the body homeostasis. We aimed to investigate the changing trend of serum levels of Ca/P/Mg in neonates.
Methods: We enrolled 82 premature newborns, 173 neonatal sepsis, 50 neonatal hypoglycemia, 254 neonatal jaundice, 43 neonatal haemolytic disease, and 59 healthy controls in our retrospective study.
A new phenotype of aldolase a deficiency in a 14 year-old boy with epilepsy and rhabdomyolysis - case report.
Ital J Pediatr
March 2022
Division of Metabolism, Department of Pediatric Subspecialties, Bambino Gesù Children's Hospital IRCCS, Rome, Italy.
Article Synopsis
- * A case study highlights a 14-year-old boy who experienced seizures and rhabdomyolysis, and suggests using a ketogenic diet alongside antiepileptic treatment to provide energy for muscles and neurons.
- * The combined treatment proved effective, as the patient tolerated the diet well and had no further episodes of seizures or rhabdomyolysis without any side effects.
Transient congenital hyperinsulinism and hemolytic disease of a newborn despite rhesus D prophylaxis: a case report.
J Med Case Rep
November 2021
Institute of Clinical Research, University of Southern Denmark, Odense, Denmark.
Background: In neonates, rhesus D alloimmunization despite anti-D immunoglobulin prophylaxis is rare and often unexplained. Rhesus D alloimmunization can lead to hemolytic disease of the newborn with anemia and unconjugated hyperbilirubinemia. In past reports, transient congenital hyperinsulinism has been described as a rare complication of rhesus D alloimmunization.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!